chr9-124889186-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002077.4(GOLGA1):c.1718G>A(p.Arg573Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000521 in 1,612,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002077.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GOLGA1 | NM_002077.4 | c.1718G>A | p.Arg573Gln | missense_variant | 18/23 | ENST00000373555.9 | NP_002068.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GOLGA1 | ENST00000373555.9 | c.1718G>A | p.Arg573Gln | missense_variant | 18/23 | 1 | NM_002077.4 | ENSP00000362656.4 | ||
GOLGA1 | ENST00000485337.1 | n.*472G>A | non_coding_transcript_exon_variant | 10/10 | 5 | ENSP00000435006.1 | ||||
GOLGA1 | ENST00000485337.1 | n.*472G>A | 3_prime_UTR_variant | 10/10 | 5 | ENSP00000435006.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250246Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135256
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1460246Hom.: 0 Cov.: 32 AF XY: 0.0000523 AC XY: 38AN XY: 726414
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74390
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at